113 related articles for article (PubMed ID: 2885357)
1. A double-blind evaluation of skin test suppression produced by two doses of terfenadine.
Bantz EW; Dolen WK; Nelson HS
J Allergy Clin Immunol; 1987 Jul; 80(1):99-103. PubMed ID: 2885357
[TBL] [Abstract][Full Text] [Related]
2. Antihistaminic activity and side effect profile of epinastine and terfenadine in healthy volunteers.
Schilling JC; Adamus WS; Kuthan H
Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):493-7. PubMed ID: 1982280
[TBL] [Abstract][Full Text] [Related]
3. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
Naclerio RM; Kagey-Sobotka A; Lichtenstein LM; Freidhoff L; Proud D
Am Rev Respir Dis; 1990 Jul; 142(1):167-71. PubMed ID: 1695070
[TBL] [Abstract][Full Text] [Related]
4. Multicenter, double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis.
Kemp JP; Buckley CE; Gershwin ME; Buchman E; Cascio FL; Chretien JH; Foster TS; Gordon WE; Jakle C; Klemawesch SJ
Ann Allergy; 1985 Jun; 54(6):502-9. PubMed ID: 2861767
[TBL] [Abstract][Full Text] [Related]
5. Comparison of terfenadine once daily with terfenadine twice daily for the treatment of perennial allergic rhinitis.
Rosario NA
J Int Med Res; 1991; 19(2):112-20. PubMed ID: 1677901
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of inhibition of wheal response to histamine by multiple doses of terfenadine.
Ryan WM
Ann Allergy; 1989 Dec; 63(6 Pt 2):609-11. PubMed ID: 2574553
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis.
Del Carpio J; Kabbash L; Turenne Y; Prevost M; Hebert J; Bedard PM; Nedilski M; Gutkowski A; Schulz J
J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):741-6. PubMed ID: 2572617
[TBL] [Abstract][Full Text] [Related]
8. A study of the anticholinergic activity of terfenadine in normal volunteers.
Vargas R; McMahon FG; Ryan JR
J Int Med Res; 1989; 17(2):157-61. PubMed ID: 2566537
[TBL] [Abstract][Full Text] [Related]
9. Loratadine (SCH29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of seasonal allergic rhinitis.
Bruttmann G; Pedrali P
J Int Med Res; 1987; 15(2):63-70. PubMed ID: 2884152
[TBL] [Abstract][Full Text] [Related]
10. Once versus twice daily dosing of terfenadine in the treatment of seasonal allergic rhinitis: US and European studies.
Chu TJ; Yamate M; Biedermann AA; Wolfe JD; Goldsobel AB
Ann Allergy; 1989 Dec; 63(6 Pt 2):612-5. PubMed ID: 2574554
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive instrumental techniques to detect terfenadine and temelastine induced suppression of histamine weals in man.
Shall L; Marks R
Br J Clin Pharmacol; 1987 Oct; 24(4):409-13. PubMed ID: 2891368
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of terfenadine and chlorpheniramine in the elderly.
Simons KJ; Martin TJ; Watson WT; Simons FE
J Allergy Clin Immunol; 1990 Mar; 85(3):540-7. PubMed ID: 2107240
[TBL] [Abstract][Full Text] [Related]
13. Antihistaminic treatment of allergic rhinitis: a double-blind study with terfenadine versus dexchlorpheniramine.
Pastorello EA; Ortolani C; Gerosa S; Pravettoni V; Codecasa LR; Fugazza A; Zanussi C
Pharmatherapeutica; 1987; 5(2):69-75. PubMed ID: 2889217
[TBL] [Abstract][Full Text] [Related]
14. Differential cognitive effects of terfenadine and chlorpheniramine.
Meador KJ; Loring DW; Thompson EE; Thompson WO
J Allergy Clin Immunol; 1989 Sep; 84(3):322-5. PubMed ID: 2570799
[TBL] [Abstract][Full Text] [Related]
15. Suppression of epicutaneous reactivity by terfenadine and loratadine.
Small P
Ann Allergy; 1992 Jan; 68(1):30-4. PubMed ID: 1346563
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological modulation of cutaneous reactivity to histamine: a double-blind acute comparative study between cetirizine, terfenadine and astemizole.
Ghys L; Rihoux JP
J Int Med Res; 1989; 17(1):24-7. PubMed ID: 2565265
[TBL] [Abstract][Full Text] [Related]
17. Start and end of the effects of terfenadine and astemizole on histamine-induced wheals in human skin.
Työlahti H; Lahti A
Acta Derm Venereol; 1989; 69(3):269-71. PubMed ID: 2566243
[TBL] [Abstract][Full Text] [Related]
18. Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.
Sorkin EM; Heel RC
Drugs; 1985 Jan; 29(1):34-56. PubMed ID: 2857636
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of skin reactivity by antihistamines.
Filderman RB
Cutis; 1988 Oct; 42(4A):19-21. PubMed ID: 2903813
[TBL] [Abstract][Full Text] [Related]
20. Lack of subsensitivity to terfenadine during long-term terfenadine treatment.
Simons FE; Watson WT; Simons KJ
J Allergy Clin Immunol; 1988 Dec; 82(6):1068-75. PubMed ID: 2904930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
